{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:17:43Z","timestamp":1791523063334,"version":"4.3.4"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T00:00:00Z","timestamp":1242691200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1000085","type":"journal-article","created":{"date-parts":[[2009,5,18]],"date-time":"2009-05-18T17:42:43Z","timestamp":1242668563000},"page":"e1000085","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":66,"title":["Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Joseph T.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lipsitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,5,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pmed.0040013","article-title":"Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions.","volume":"4","author":"V Colizza","year":"2007","journal-title":"PLoS Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature04017","article-title":"Strategies for containing an emerging influenza pandemic in Southeast Asia.","volume":"437","author":"NM Ferguson","year":"2005","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic.","volume":"442","author":"NM Ferguson","year":"2006","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1073\/pnas.0601266103","article-title":"Mitigation strategies for pandemic influenza in the United States.","volume":"103","author":"TC Germann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1371\/journal.pmed.0040015","article-title":"Antiviral resistance and the control of pandemic influenza.","volume":"4","author":"M Lipsitch","year":"2007","journal-title":"PLoS Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source.","volume":"309","author":"IM Longini Jr","year":"2005","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1371\/journal.pmed.0030361","article-title":"Reducing the impact of the next influenza pandemic using household-based public health interventions.","volume":"3","author":"JT Wu","year":"2006","journal-title":"PLoS Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.2807\/esm.12.04.00698-en","article-title":"Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006\/2007 season.","volume":"12","author":"A Meijer","year":"2007","journal-title":"Euro Surveill"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1086\/518939","article-title":"John F. Enders lecture 2006: antivirals for influenza.","volume":"196","author":"AK Ong","year":"2007","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1086\/424572","article-title":"Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.","volume":"190","author":"ML Herlocher","year":"2004","journal-title":"J Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jac\/dkg136","article-title":"A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.","volume":"51","author":"NM Ferguson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref12","first-page":"179","article-title":"Update: influenza activity\u2013United States, September 30, 2007\u2013February 9, 2008.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.","volume":"301","author":"NJ Dharan","year":"2009","journal-title":"Jama"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007\u201308.","volume":"15","author":"SH Hauge","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 Season.","volume":"15","author":"A Meijer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMp0900648","article-title":"Global transmission of oseltamivir-resistant influenza.","volume":"360","author":"A Moscona","year":"2009","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide in 2004\u20132008.","volume":"52","author":"TG Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","article-title":"Oseltamivir-resistant influenza a viruses circulating in Japan.","author":"D Tamura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1098\/rspb.2007.0422","article-title":"Emergence of drug resistance: implications for antiviral control of pandemic influenza.","volume":"274","author":"ME Alexander","year":"2007","journal-title":"Proc Biol Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1126\/science.1122947","article-title":"Emergence of drug-resistant influenza virus: population dynamical considerations.","volume":"312","author":"RR Regoes","year":"2006","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1086\/515246","article-title":"Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.","volume":"177","author":"NI Stilianakis","year":"1998","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nature03063","article-title":"Transmissibility of 1918 pandemic influenza.","volume":"432","author":"CE Mills","year":"2004","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/aje\/kwj362","article-title":"Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.","volume":"165","author":"ME Halloran","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1467-9876.2006.00539.x","article-title":"Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups.","volume":"55","author":"Y Yang","year":"2006","journal-title":"J R Stat Soc Ser C Appl Stat"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1098\/rspb.2006.0015","article-title":"What is the best control strategy for multiple infectious disease outbreaks?","volume":"274","author":"A Handel","year":"2007","journal-title":"Proc Biol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"48","author":"F Hayden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.antiviral.2006.01.012","article-title":"Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.","volume":"70","author":"NA Ilyushina","year":"2006","journal-title":"Antiviral Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/135965350701200302","article-title":"Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.","volume":"12","author":"NA Ilyushina","year":"2007","journal-title":"Antivir Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1179\/joc.2007.19.3.295","article-title":"Low dose oral combination chemoprophylaxis with oseltamivir and amantadine for influenza A virus infections in mice.","volume":"19","author":"KN Masihi","year":"2007","journal-title":"J Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1371\/journal.pmed.0030212","article-title":"Delaying the international spread of pandemic influenza.","volume":"3","author":"BS Cooper","year":"2006","journal-title":"PLoS Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/AAC.18.4.536","article-title":"Enhancement of activity against influenza viruses by combinations of antiviral agents.","volume":"18","author":"FG Hayden","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.","volume":"8","author":"MG Ison","year":"2003","journal-title":"Antivir Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jinf.2007.09.002","article-title":"A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.","volume":"56","author":"N Kawai","year":"2008","journal-title":"J Infect"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1086\/518385","article-title":"Zanamivir treatment is equally effective for both influenza A and influenza B.","volume":"44","author":"N Kawai","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.","volume":"453","author":"PJ Collins","year":"2008","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/dkl321","article-title":"Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.","volume":"58","author":"T Zurcher","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2007.10.020","article-title":"Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.","volume":"41","author":"O Ferraris","year":"2008","journal-title":"J Clin Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/jmv.20951","article-title":"Neuraminidase inhibitor resistance in influenza viruses.","volume":"79","author":"PA Reece","year":"2007","journal-title":"J Med Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","article-title":"The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.","volume":"55","author":"JAL Ives","year":"2002","journal-title":"Antiviral Research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1125237","article-title":"Synchrony, waves, and spatial hierarchies in the spread of influenza.","volume":"312","author":"C Viboud","year":"2006","journal-title":"Science"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1000085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T01:49:36Z","timestamp":1684979376000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1000085"}},"subtitle":[],"editor":[{"given":"C\u00e9cile","family":"Viboud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,5,19]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,5,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1000085","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1159352.619699","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,19]]}}}